A business in context

ENTA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-345719

  2. 4 · Ownership change

    Report date 2026-08-08 · 0002064832-26-000266

  3. 8-K · Current report

    Report date 2026-08-10 · 0001193125-26-342336 · Items 2.02,9.01

  4. 8-K · Current report

    Report date 2026-07-02 · 0001193125-26-294837 · Items 1.01,9.01

  5. 8-K · Current report

    Report date 2026-06-23 · 0001193125-26-279803 · Items 8.01

  6. 8-K · Current report

    Report date 2026-06-18 · 0001193125-26-274950 · Items 7.01,9.01

  7. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-220572

  8. 8-K · Current report

    Report date 2026-05-11 · 0001193125-26-216735 · Items 2.02,9.01

  9. 8-K · Current report

    Report date 2026-03-20 · 0001193125-26-125113 · Items 8.01

  10. 4 · Ownership change

    Report date 2026-03-11 · 0002064832-26-000143

  11. 4 · Ownership change

    Report date 2026-03-11 · 0002064832-26-000142

  12. 4 · Ownership change

    Report date 2026-03-11 · 0002064832-26-000141

  13. 4 · Ownership change

    Report date 2026-03-11 · 0002064832-26-000140

  14. 4 · Ownership change

    Report date 2026-03-11 · 0002064832-26-000139

  15. 4 · Ownership change

    Report date 2026-03-11 · 0002064832-26-000138

  16. 8-K · Current report

    Report date 2026-03-11 · 0001193125-26-104109 · Items 5.02,5.07,9.01

  17. 4 · Ownership change

    Report date 2026-02-12 · 0002064832-26-000016

  18. 10-Q · Quarterly report

    Report date 2025-12-31 · 0001193125-26-046502

  19. 8-K · Current report

    Report date 2026-02-09 · 0001193125-26-042812 · Items 2.02,9.01

  20. DEF 14A · Proxy statement

    Report date 2026-03-11 · 0001193125-26-022558

  21. 10-K · Annual report

    Report date 2025-09-30 · 0001193125-25-288121

  22. 8-K · Current report

    Report date 2025-11-17 · 0001193125-25-284633 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-09-30 · 0001193125-25-226828 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2025-09-29 · 0001193125-25-221791 · Items 7.01,9.01

  25. 8-K · Current report

    Report date 2025-09-29 · 0001193125-25-221527 · Items 7.01,8.01,9.01

  26. 8-K · Current report

    Report date 2025-08-26 · 0001193125-25-189691 · Items 5.02

  27. 8-K · Current report

    Report date 2025-08-20 · 0001193125-25-183719 · Items 7.01,8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001193125-25-179795

  29. 8-K · Current report

    Report date 2025-08-11 · 0001193125-25-177941 · Items 2.02,9.01

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-071340

  31. 8-K · Current report

    Report date 2025-05-12 · 0000950170-25-069155 · Items 2.02,9.01

  32. 8-K · Current report

    Report date 2025-03-13 · 0000950170-25-040230 · Items 5.02,5.07,9.01

  33. 10-Q · Quarterly report

    Report date 2024-12-31 · 0000950170-25-018810

  34. 8-K · Current report

    Report date 2025-02-10 · 0000950170-25-017035 · Items 2.02,9.01

  35. DEF 14A · Proxy statement

    Report date 2025-03-13 · 0000950170-25-009168

  36. 8-K · Current report

    Report date 2024-12-09 · 0001193125-24-272936 · Items 7.01,8.01,9.01

  37. 10-K · Annual report

    Report date 2024-09-30 · 0000950170-24-131260

  38. 8-K · Current report

    Report date 2024-11-25 · 0000950170-24-130553 · Items 2.02,9.01

  39. SC 13G/A · Ownership disclosure

    0001172661-24-005156

  40. SC 13G/A · Ownership disclosure

    0001273087-24-000102

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

1 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-08
2026-08-10
Rottinghaus Scott T.F · Tax / exercise payment
Disposed
Common Stock1467.013.34

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001177648ENANTA PHARMACEUTICALS INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2025-09-30$65.32M$68.78M
    2024-09-30$67.64M$73.14M
    2023-09-30$79.20M$88.28M
    2022-09-30$86.16M$100.90M
    2021-09-30$97.07M$122.67M
    2020-09-30$122.47M$159.94M
    2019-09-30$205.20M$271.79M
    2018-09-30$206.62M$278.76M

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗